These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16122672)

  • 1. Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.
    Bicanic T; Wood R; Bekker LG; Darder M; Meintjes G; Harrison TS
    Lancet Infect Dis; 2005 Sep; 5(9):530-1. PubMed ID: 16122672
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating cryptococcal meningitis in people with HIV.
    BMJ; 2013 Apr; 346():f2203. PubMed ID: 23575571
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of cryptococcal meningitis.
    Larsen RA
    N Engl J Med; 1997 Nov; 337(21):1557; author reply 1557-8. PubMed ID: 9380127
    [No Abstract]   [Full Text] [Related]  

  • 4. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 5. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
    Loyse A; Dromer F; Day J; Lortholary O; Harrison TS
    J Antimicrob Chemother; 2013 Nov; 68(11):2435-44. PubMed ID: 23788479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].
    Pintado García V; Martín Dávila P; Muñoz Labián V; Quereda Rodríguez-Navarro C
    Rev Clin Esp; 1999 Jul; 199(7):480. PubMed ID: 10481571
    [No Abstract]   [Full Text] [Related]  

  • 7. [Focusing on therapy of systemic mycoses].
    Internist (Berl); 1995 Dec; 36(12 Suppl):1-12. PubMed ID: 9022383
    [No Abstract]   [Full Text] [Related]  

  • 8. Episodic third nerve palsy with cryptococcal meningitis.
    Azran MS; Waljee A; Biousse V; Frankel M; Newman NJ
    Neurology; 2005 Feb; 64(4):759-60. PubMed ID: 15728316
    [No Abstract]   [Full Text] [Related]  

  • 9. Ending deaths from HIV-related cryptococcal meningitis by 2030.
    Shroufi A; Chiller T; Jordan A; Denning DW; Harrison TS; Govender NP; Loyse A; Baptiste S; Rajasingham R; Boulware DR; Ribeiro I; Jarvis JN; Van Cutsem G
    Lancet Infect Dis; 2021 Jan; 21(1):16-18. PubMed ID: 33271065
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal meningitis in pediatric AIDS.
    Kaur R; Rawat D; Kakkar M; Monga R; Sharma VK
    J Trop Pediatr; 2003 Apr; 49(2):124-5. PubMed ID: 12729297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
    Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
    Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to flucytosine for HIV-infected patients with cryptococcal meningitis – an urgent need.
    Govender NP; Meintjes G; Banoo S
    S Afr Med J; 2014 Sep; 104(9):594-5. PubMed ID: 26307779
    [No Abstract]   [Full Text] [Related]  

  • 14. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcal meningitis in HIV-infected patients.
    Leenders AC; van der Ende ME; van der Ree TC; de Marie S
    AIDS; 1994 Dec; 8(12):1741-3. PubMed ID: 7888131
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries.
    Loyse A; Thangaraj H; Easterbrook P; Ford N; Roy M; Chiller T; Govender N; Harrison TS; Bicanic T
    Lancet Infect Dis; 2013 Jul; 13(7):629-37. PubMed ID: 23735626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B: the higher the dose, the higher the toxicity.
    Pasqualotto AC
    Clin Infect Dis; 2008 Oct; 47(8):1110; author reply 1110-1. PubMed ID: 18800934
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of cryptococcal meningitis.
    Zingman BS
    N Engl J Med; 1997 Nov; 337(21):1557; author reply 1557-8. PubMed ID: 9380128
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical efficacy of itraconazole with initial flucytosine in AIDS-related cryptococcal meningitis: a preliminary study.
    Riantawan P; Ponglertnapakorn P
    J Med Assoc Thai; 1996 Jul; 79(7):429-33. PubMed ID: 8855621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cryptococcal meningitis with short-course amphotericin B and flucytosine, followed by itraconazole.
    Chotmongkol V; Jitpimolmard S
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):99-101. PubMed ID: 8395739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.